MPP Symposium at the 48th Union World Conference on Lung Health – Friday 13 October at 14h00
The Medicines Patent Pool Adds Three New Partners to Generic Network
MPP statement on addressing the global shortage of, and access to, medicines and vaccines
MPP statement on the evaluation and review of the Global Strategy and Plan of Action on Public Health, Innovation and IP
Debate at the World Health Assembly: Delivering Appropriate Treatment to Low- and Middle-Income Countries
MPP statement on Antimicrobial resistance at the 70th World Health Assembly
MPP-WHO event – Forecasts vs. Reality: Are we on Course?
Intervention by the MPP at the 21st Expert Committee on the Selection and Use of Essential Medicines
Opening remarks by Dr. Ren Minghui (WHO) at MPP-WHO joint event
MPP’s Winter Newsletter
The MPP publishes its February 2017 newsletter featuring an update on its last six months of progress.
Invitation to submit interest in a sub-licence for sutezolid
MPP intervention at the 140th World Health Organization Executive Board, January 27, 2017
MPP’s next steps in tuberculosis: Stewardship Report
The MPP Intervention on Intellectual Property, 39th Meeting of the UNAIDS Programme Coordinating Board, December 7, 2016
The Medicines Patent Pool Publishes Peer-Reviewed Paper on Forecasting Antiretrovirals in Low- and Middle-Income Countries (LMICs)
MPP’s summer newsletter
The MPP publishes its July 2016 newsletter featuring an update on its last six months of progress.
The New York Times – New strategies to fight AIDS
Voluntary Patent Pooling: Encouraging Rapid Scale-Up of Medicines for Resource-Limited Countries
Medicines Patent Pool statement, 69th World Health Assembly
Generics Bulletin: “Medicines Patent Pool has potential for wider scope”
MPP Submission to the UN High-Level Panel on Access to Medicines
MPP Newsletter – January 2016
One licence for a HCV medicine, two new disease areas, four new board members, $120 million in savings: check out MPP’s January newsletter for an update on top initiatives in Q3/Q4 2015.
Global Innovative Financing for the Next Decade
Greg Perry and Philippe Douste-Blazy in Global Health and Diplomacy Magazine
New agreements for TAF signed with Lupin and Micro Labs
Ensuring new medicines reach those in most need
ARV forcasts presented at IAS 2015
UNITAID and MPP publish ARV Snapshot Report
MPP Newsletter July 2015
Progress and Achievements Report
MPP 2014 Annual Report
Watch a Video Interview with G. Perry
Recent Achievements and Impact
UNITAID Board Decision To Continue Funding The Medicines Patent Pool
(FR) “Sida: vers la fin de l’épidémie?” – radio interview
New Statement from the Executive Director
BBC World Service – Interview with G. Perry (Dec. 1)
UNITAID: Over $1 Billion Saved by 2028 Through Medicines Patent Pool Licensing Agreements!
MPP’s ED Participates in World Investment Forum Panel
UNITAID Welcomes the Medicines Patent Pool’s Negotiation of Six New Sub-licences for Key HIV Medicines
MPP Hosts Side Event at the WIPO General Assemblies
MPP Newsletter – September 2014
Greg Perry discusses the future of HIV treatment at AIDS2014
MPP Brochure: Building Partnerships – Accelerating Access
Voice of America News: Greg Perry on the PHTI
MPP Launches 2013 Annual Report
WHA Resolutions on Access to Medicines and Innovative Financing
The MPP lauds the resolutions passed over the weekend at the 67th World Health Assembly on access to essential medicines and on innovative financing. Read the statement.
UNITAID welcomes ViiV latest collaboration with MPP
Read the full statement on the UNITAID’s website.